BI-1701963
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for BI-1701963, covering 2024-12-16 to 2026-01-12. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Test Different Doses of BI 1701963 Alone and Combined With Trametinib in Patients With Different Types of Advanced Cancer (Solid Tumours With KRAS Mutation) [Phase 1]